Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
<p class="MsoNormal" style="margin: 1pt 7.0865pt; text-align: justify;"><strong><span style="font-weight: bold; font-family: Tahoma;">Background</span></strong><span style="font-family: Tahoma;"><strong>:</strong>...
Saved in:
Main Authors: | Leslie Pérez Ruiz, Ana María Ramos Cedeño, José Cabrera Gómez, Nancy Echazábal Santana, Hailen Bobillo López |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2007-12-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/288 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01) -
Adverse Reactions due to the Usage Ofadverse Effects due to the Usage of T biomodulina and corticotropin in Patients Suffering from Multiple Sclerosis
by: Rosa F. Lara Rodríguez, et al.
Published: (2007-05-01) -
A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients
by: M.-C. Boll, et al.
Published: (2025-01-01) -
Preventive vaccines for COVID-19. An expectant reality
by: Ana María Ramos Cedeño, et al.
Published: (2020-11-01) -
Tuberous sclerosis. Case presentation.
by: Graciela Caridad Cabrera Acea, et al.
Published: (2009-03-01)